First study to show obesity-related cancer risk is 1.5-fold higher in people with metabolic aberrations as well as obesity, compared with metabolically healthy and normal weight individuals.
Combining Moderna s patient-specific mRNA-based cancer vaccine with pembrolizumab may prolong recurrence-free survival in patients with high-risk melanoma vs pembrolizumab alone, new data show.
After finding that immune checkpoint inhibitors (ICIs) do not work as well for patients who had taken antibiotics, the investigators suggest restoring the gut microbiome before starting therapy.